Hypersecretion of proinsulin in thyrotoxicosis

Area of Science:

• Endocrinology
• Metabolic Disorders
• Hormone Research

Background:

• Thyrotoxicosis, a condition of excess thyroid hormones, can affect metabolic processes.
• Understanding hormonal changes in thyrotoxicosis is crucial for patient management.
• Proinsulin levels and their role in metabolic regulation require further investigation.

Purpose of the Study:

• To investigate plasma insulin, C-peptide, and proinsulin concentrations in thyrotoxic patients.
• To compare these levels with euthyroid controls under various physiological conditions.
• To determine the impact of thyrotoxicosis on proinsulin and insulin measurements.

Main Methods:

• Measurements of plasma insulin, C-peptide, and proinsulin.
• Study groups included thyrotoxic patients and normal euthyroid controls.
• Tests included overnight fasting, prolonged fasting (36h), intravenous glucose tolerance test (IVGTT), and oral glucose tolerance test (OGTT).

Main Results:

• Significantly higher plasma proinsulin concentrations were observed in thyrotoxic patients compared to controls.
• Proinsulin levels were elevated in thyrotoxic patients during fasting and glucose tolerance tests.
• Insulin measurements, when corrected for proinsulin cross-reactivity, were similar between groups.

Conclusions:

• Elevated proinsulin is a key finding in thyrotoxicosis.
• Proinsulin cross-reactivity can artifactually inflate insulin measurements in thyrotoxicosis.
• C-peptide levels remained largely unaffected by thyrotoxicosis during glucose tolerance tests.